Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Surface-modified nanostructured lipid carriers can improve hair growth treatments.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Angelica Dahurica extract helps reduce hair loss and improve hair growth and scalp condition.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

People with cutaneous Lichen Planus are more likely to have Metabolic Syndrome and related conditions like high cholesterol, diabetes, and high blood pressure.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

The summit concluded that new treatments like Jak inhibitors show promise for Alopecia Areata and personalized approaches are needed.

Protein analysis shows aging changes in scalp cell types from women.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

CXCL12 protein slows down hair growth through its receptor CXCR4. Blocking this can potentially increase hair growth.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Certain gene variations and different levels of BDNF and CRH hormones are linked to vitiligo.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Black and Hispanic women are more likely to have alopecia areata than white women.

Hair follicle-derived extracellular vesicles may help heal chronic wounds as effectively as those from adipose tissue.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

The study concluded that people with Lichen Planopilaris have a more diverse scalp bacteria and different metabolic pathways compared to healthy individuals.

Alopecia Areata is linked to specific gut bacteria and metabolites, indicating a complex gut microbiome.

Obesity and bariatric surgery can cause hair thinning and temporary hair loss due to nutritional deficiencies and stress.

Platelet-rich plasma therapy is a safe and effective treatment for alopecia areata.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Imbalance in scalp bacteria can affect hair and scalp health, potentially leading to conditions like hair loss, psoriasis, and dandruff.